The study investigates the effect of a single-session, 4 hour, transdiagnostic treatment for primary care patientst with depression, anxiety or stress.~The treatment includes, interoceptive exposure, behavioral activation, mindfulness, defusion and psycho-education about emotions.~The study is conducted in a clinical setting in northern sweden and follows up results at 3 weeks and 6 months post treatment.
The goal of this clinical trial is to test a single session treatment program in primary care patients with anxiety and/or depression and/or stress-related issues. The main questions it aims to answer is:~Will the transdiagnostic treatment program decrease symptoms of depression/anxiety/stress?~Will the transdiagnostic treatment program decrease transdiagnostic risk factors?~Will the transdiagnostic treatment program decrease the measured risk factors equally?~Will the transdiagnostic treatment program impact patients with anxiety, depression or stress disorders equally?~Will the transdiagnostic treatment program have long term (6 months post-treatment) effect on transdiagnostic risk factors?~Will the transdiagnostic treatment program have long term (6 months post-treatment) effect on anxiety, depression, or stress-symptoms?~Have the participants been able to generalize the skills taught in the program(qualitative)?~Within group that were treated with single-session treatment and recieved additional care before follow-up, was there a difference in outcome?